Clinical Trial

UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)

Name: UBT251 Injection Phase Ⅲ Study (Overweight or Obesity) — clinical trial record (NCT07648225)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This randomized, double-blind, parallel, placebo-controlled phase Ⅲ study to evaluate the efficacy and safety of UBT251 Injection in overweight/obese patients

Trial Details

NCT Number	NCT07648225
Lead Sponsor	The United Bio-Technology (Hengqin) Co., Ltd.
Conditions	Obesity & Overweight
Enrollment	600 participants
Start Date	2026-07-31
Primary Completion	2027-09-29 (estimated)
Study Completion	2027-11-03 (estimated)
Updated on ClinicalTrials.gov	2026-06-15